Tongue test to improve colorectal cancer screening
Part of Cancer, Digestive system clinical trials.
This study is testing a new, non-invasive tongue test called Gixam. The goal is to see if the test can help detect colorectal cancer or pre-cancerous growths in people whose standard stool tests (FIT) came back negative, potentially improving screening accuracy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 45 and 84 years old
- Have average risk for colorectal cancer (no personal or family history)
- Are already scheduled for a screening colonoscopy
- Have not had a positive stool test (FIT or FOBT) in the past 11 months
- Have not had a positive Cologuard or similar test in the past 3 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new test (called Gixam) that uses a sample from your mouth to help find pre-cancerous growths or colorectal cancer. It may offer a less invasive way to check for cancer risk when you already need a colonoscopy.
This trial tests a new device called Gixam to see if it can help find colorectal cancer in people who recently had a normal FIT test (a stool test for blood). You may be able to join if you are between 45 and 85 years old and are already scheduled for a routine screening colonoscopy.
This trial tests a new tool that looks at gut bacteria to help find colorectal cancer earlier. It's for people who already had a positive result on a standard stool test (FIT) as part of a national screening program.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
This trial tests a new stool-based screening test that may find colorectal cancer and advanced adenomas (precancerous growths) early. It studies whether the test works well compared with the standard colonoscopy, so it could offer an easier, less invasive screening option in the future.
This study aims to find a better way to screen for stomach and colon cancers. You will be asked to provide a stool sample, and possibly have an endoscopy (a camera test), to see if combined screening can catch cancer early.
Hear when a new CRC Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.